+Vote!
PR News Wire (Free subscription) | 27/08/2008
LAKE FOREST, Ill., Aug. 27 /PRNewswire-FirstCall/ -- Hospira, Inc.
(NYSE: ), a global specialty pharmaceutical and medication delivery
company, today announced that Christopher B. Begley, chairman and chief
executive officer, will make a formal presentation at the Morgan Stanley
2008 Healthcare Conference on Tuesday, Sept. 9, 2008, at the Grand Hyatt in
New York City.
The presentation is scheduled...
+Vote!
Red Orbit (Free subscription) | 21/08/2008
LAKE FOREST, Ill., Aug. 21 /PRNewswire-FirstCall/ -- Hospira, Inc. , a global specialty pharmaceutical and medication delivery company, today announced new national agreements with Premier Purchasing Partners.
+Vote!
Financial Services (Free subscription) | 13/08/2008
Hospira Inc (HSP) more shares bought by Rockefeller Financial …Mffais.com, CA - 1 hour agoLONG BEACH (Mffais.com) - Rockefeller Financial Services Inc added additional 14 (0.09 %) shares of Hospira Inc (HSP), bringing their current holdings to …
+Vote!
Chicago Tribune (Free subscription) | 06/08/2008
Hospira Inc.'s second-quarter net income more than doubled on surging margins as the company's acquisition last year of Mayne Pharma helped drive growth in its injectable-pharmaceuticals business.
+Vote!
Market Watch (Free subscription) | 06/08/2008
NEW YORK (MarketWatch) -- Hospira Inc. said Wednesday that its second-quarter profit more than doubled to $69.1 million, or 43 cents a share, from $30.7 million, or 20 cents a share, in the year-ago period. Adjusted earnings rose to 57 cents a share from 49 cents a share. Net sales rose 3.7% to $901.6 million from $869.3 million. Analysts surveyed by FactSet Research forecast earnings of 62 cents...
+Vote!
Patent Appeal Tracer (Free subscription) | 06/08/2008
2008-1499 Aventis Pharma v. Hospira CD/CA 07-CV-8137 Judge Mariana R. Pfaelzer Aventis has appealed from Judge Pfaelzer's Order granting Hospira's motion for judgment on the pleadings and dismissing Aventis's infringement claim with prejudice based on collateral estoppel. Aventis owns U.S....
+Vote!
Chicago Tribune (Free subscription) | 15/07/2008
Workers claim deception on post-spinoff benefits Abbott Laboratories, the fourth-biggest U.S. drugmaker, must face a trial on claims it deceived workers who joined its Hospira Inc. spinoff about whether their benefits would be cut after they did so.
+Vote!
The Street (Free subscription) | 11/07/2008
Cramer thinks highly of Hospira, which makes generic drugs that are ready to use in disposable syringes.
+Vote!
The Street (Free subscription) | 11/07/2008
Cramer thinks highly of Hospira, which makes generic drugs that are ready to use in disposable syringes.
+Vote!
PR News Wire (Free subscription) | 07/07/2008
LAKE FOREST, Ill., July 7 /PRNewswire-FirstCall/ -- Hospira, Inc.
(NYSE: ), a global specialty pharmaceutical and medication delivery
company, today announced that it will host a conference call to discuss its
second-quarter 2008 results on Wednesday, Aug. 6, 2008, at 8 a.m. Central
time.
The company will release its second-quarter results earlier that
morning, before the U.S. stock market open and...
+Vote!
Contract Pharma Breaking News (Free subscription) | 02/07/2008
Altea Therapeutics has entered into a partnership with Hospira for the development and commercialization of an undisclosed product using its PassPort Transdermal Delivery System. Under the terms of the agreement, Hospira has exclusive worldwide rights to develop and commercialize the product. Altea will fund certain Phase I studies and Hospira will fund all further product development, manufacturing,...
